University of Calgary’s Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that ...
News Medical on MSN3d
ESCAPE-MeVO trial advances understanding of stroke treatment for medium-sized vessel blockagesUniversity of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot ...
This advertisement has not loaded yet, but your article continues below.
One in six deaths from cardiovascular disease in the United States is due to stroke, and over 100 million people worldwide have had a stroke, which is a leading cause of serious long-term disability.
Whether the large effect size of endovascular thrombectomy (EVT) for stroke due to large-vessel occlusion applies to stroke due to medium-vessel occlusion is unclear. In a multicenter, prospective ...
This advertisement has not loaded yet, but your article continues below.
With plenty of rumours and reports swirling around the CFL, CFL.ca’s Marshall Ferguson counts down his top 10 moves during the free agency communication window.
A total of 1352 patients were analyzed with a mean follow-up of 2.5 years; 681 received eprosartan and 671 received nitrendipine. Both treatment groups were similar with respect to baseline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback